Treatment of Major Depressive Disorder in Japanese Patients with Cancer: A Matched Cohort Study Using Employer-Based Health Insurance Claims Data.
Tatsuo AkechiShinji FujimotoIzumi MishiroKatsuhito MurasePublished in: Clinical drug investigation (2020)
These results suggest Japanese patients with cancer may be undertreated for MDD compared with cancer-free patients. However, when prescribed, medications may be chosen according to patient needs, including avoiding adverse effects and drug-drug interactions.
Keyphrases
- major depressive disorder
- health insurance
- bipolar disorder
- end stage renal disease
- ejection fraction
- affordable care act
- chronic kidney disease
- newly diagnosed
- case report
- papillary thyroid
- peritoneal dialysis
- healthcare
- prognostic factors
- squamous cell carcinoma
- emergency department
- machine learning
- squamous cell
- data analysis
- drug induced
- replacement therapy